The clinicopathologic significance of unilateral adrenal cortical hyperplasia: Report of an unusual case and a review of the literature

Endocrine Pathology

Volumn 10, Issue 3, 1999, Pages 243-249

  Lam, King Yin ^a,b   Lo, Chung Yau ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Adrenal; Aortic dissection; Unilateral cortical hyperplasia

Indexed keywords

ADRENAL GLAND; ADRENALECTOMY; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; ENZYME ACTIVITY; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL;

EID: 0032744279     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02738886     Document Type: Article

References (28)

1. 1. Lam KY. Adrenal tumors in Chinese. Virchows Arch A 421:13-16, 1992.
2. 2. Lo CY, Tam PC, Kung AWC, Lam KSL, Wong J. Primary aldosteronism: results of surgical treatment. Ann Surg 224:125-130, 1996.
3. 3. Ross EJ. Conn's syndrome due to adrenal hyperplasia with hypertrophy of zona glomerulosa, relieved by unilateral adrenalectomy. Am J Med 39:994-1002, 1965.
4. 4. Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, et al. Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med 90:386-395, 1979.
5. 5. Ganguly A, Zager PG, Luetscher JA.Primary aldosteronism due to unilateral adrenal hyperplasia. J Clin Endocrinol Metab 51:1190-1194, 1980.
6. 6. Mendlowitz M. A case of predominantly unilateral pseudoprimary hyperaldosteronism. Mt Sinai J Med 49:76-77, 1982.
7. 7. Ganguly A, Yum MN, Pratt JH, Weinberger MH, Grim CE, Yune HY, et al.Unilateral hypersecretion of aldosterone associated with adrenal hyperplasia as a cause of primary aldosteronism. Clin Exp Hypertens A 5:635-658, 1983.
8. 8. Oberfield SE, Levine LS, Firpo A, Lawrence D Sr, Stoner E, Levy DJ, et al. Primary hyperaldosteronism in childhood due to unilateral macronodular hyperplasia: case report. Hypertension 6:75-84, 1984.
9. 9. Kem DC, Tang K, Hanson CS, Brown RD, Painton R, Weinberger MH, et al. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels. J Clin Endocrinol Metab 60:67-73, 1985.
10. 10. Lim RC Jr, Nakayama DK, Biglieri EG, Schambelan M, Hunt TK. Primary aldosteronism: changing concepts in diagnosis and management. Am J Surg 152:116-121, 1986.
11. 11. Dye NV, Litton NJ, Varma M, Isley WL. Unilateral adrenal hyperplasia as a cause of primary aldosteronism. South Med J 82:82-86, 1989.
12. 12. Sasagawa I, Nakada T, Hashimoto T, Kato T, Suzuki H, Ishigooka M, et al. Unilateral diffuse adrenal hyperplasia masquerading as aldosterone-producing adenoma in primary hyperaldosteronism. Urol Int 50:218-222, 1993.
13. 13. Pignatelli D, Falcao H, Coimbra-Peixoto A, Cruz F. Unilateral adrenal hyperplasia. South Med J 87:664-667, 1994.
14. 14. Edwards CRW. Primary mineralcorticoid excess syndrome. In: DeGroot LJ, Besser M, Burger HG, Jameson JL, Loriaux DL, Marsahall JC, Odell WD, Potts JT Jr, Rubenstein AH, eds. Endocriniology, 3rd ed. Philaldelphia: WB Saunders, 1775-1803, 1995.
15. 15. Abdelhamid S, Muller-Lobeck H, Pahl S, Remberger K, Bonhof JA, Walb D, et al. Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients. Arch Intern Med 156:1190-1195, 1996.
16. 16. Chen LG, Lee TI, Lin HD, Wang HC, Liu WY, Tang KT. Primary aldosteronism due to unilateral adrenal hyperplasia: a case report. Chin Med J Taipei 59:114-120, 1997.
17. 17. Siren J, Valimaki M, Huikuri K, Sivula A, Voutilainen P, Haapiainen R Adrenalectomy for primary aldosteronism: long-term follow-up study in 29 patients. World J Surg 22:418-21, 1998.
18. 18. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
19. 19. Lam AKY, Chan ACL. Aortic aneurysm at autopsy: a five year survey in Hong Kong. Am J Cardiovasc Pathol 4:31-40, 1992.
20. 20. Winfield HN, Hamilton BD, Bravo EL, Novick AC. Laparoscopic adrenalectomy: the preferred choice? A comparison to open adrenalectomy. J Urol 160:325-329, 1998.
21. 21. Ting AC, Lo CY, Lo CM. Posterior or laparoscopic approach for adrenalectomy. Am J Surg 175:488-490, 1998.
22. 22. Gasman D, Droupy S, Koutani A, Salomon L, Antiphon P, Chassagnon J, et al. Laparoscopic adrenalectomy: the retroperitoneal approach. J Urol 159:1816-1820, 1998.
23. 23. Heniford BT, Iannitti DA, Hale J, Gagner M.The role of intraoperative ultrasonography during laparoscopic adrenalectomy. Surgery 1997;1068-1073, 1997.
24. 24. Mercan S, Seven R, Ozarmagan S, Tezelman S.Endoscopic retroperitoneal adrenalectomy. Surgery 118:1071-1075, 1995.
25. 25. Soría JC, Vielh P, El-Naggar AK. Telomerase activity in cancer: a magic bullet or a mirage? Adv Anat Pathol 5:86-94, 1998.
26. 26. Autexier C, Greider CW. Telomerase and cancer: revisiting the telomere hypothesis. Trends Biochem Sci 21:387-391, 1996.
27. 27. Cheng AJ, Lin JD, Chang T, Wang TC. Telomerase activity in benign and malignant human thyroid tissues. Br J Cancer 77:2177-2180, 1998.
28. 28. Saito T, Schneider A, Martel N, Mizumoto H, Bulgay-Moerschel M, Kudo R, et al. Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis. Biochem Biophys Res Commun 231:610-614, 1997.